Patents by Inventor Dongfeng Zhang
Dongfeng Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11664256Abstract: The application discloses a placement system for a door of a wafer pod, including a loadport. A docking interface is formed in the loadport, a placement mechanism is arranged on one side surface of the loadport, and includes a swing component, a follower component, and a docking plate. The swing component and the follower component are respectively connected to the docking plate, and the swing component can drive the docking plate to place the docking plate obliquely above the docking interface. By utilizing the space at the top of the loadport, the structural layout of the loadport is more reasonable; and the docking plate is placed nearly horizontally after the door is placed at a designated position, and provides a supporting force to the door, so that dependence on the vacuum suction is decreased, thereby avoiding the influences due to fluctuations of air pressure.Type: GrantFiled: October 12, 2022Date of Patent: May 30, 2023Inventors: Dongfeng Zhang, Weicheng Bao, Wenguang Wang, Xuchen Wang, Ying Ye
-
Publication number: 20230029491Abstract: The application discloses a placement system for a door of a wafer pod, including a loadport. A docking interface is formed in the loadport, a placement mechanism is arranged on one side surface of the loadport, and includes a swing component, a follower component, and a docking plate. The swing component and the follower component are respectively connected to the docking plate, and the swing component can drive the docking plate to place the docking plate obliquely above the docking interface. By utilizing the space at the top of the loadport, the structural layout of the loadport is more reasonable; and the docking plate is placed nearly horizontally after the door is placed at a designated position, and provides a supporting force to the door, so that dependence on the vacuum suction is decreased, thereby avoiding the influences due to fluctuations of air pressure.Type: ApplicationFiled: October 12, 2022Publication date: February 2, 2023Applicant: Shanghai GoNa Semiconductor Technology Co., Ltd.Inventors: Dongfeng Zhang, Weicheng Bao, Wenguang Wang, Xuchen Wang, Ying Ye
-
Publication number: 20220322262Abstract: A method and an apparatus for signal synchronization are disclosed. The method for signal synchronization includes: A self-synchronizing first terminal device broadcasts first synchronization information, determines whether the first terminal device and a second terminal device have implemented signal synchronization when receiving second synchronization information sent by the second terminal device, and determines, based on a determining result, whether to synchronize with the second terminal device. This reduces a probability of communication interruption caused by synchronization source switching by the first terminal device after the second terminal device performs synchronization by using the first terminal device as a synchronization source. The method for signal synchronization may be applied to scenarios such as the intelligent driving, intelligent connected vehicles, and internet of vehicles.Type: ApplicationFiled: June 23, 2022Publication date: October 6, 2022Inventors: Zhiwu YANG, Dongfeng ZHANG, Kai LIU, Tiegen HU, Guowei OUYANG
-
Patent number: 11332477Abstract: The present invention discloses a nitrogen-containing heterocyclic substituted benzoxazine oxazolidinone compound, a preparation method and use thereof in the manufacture of a medicament for treating and/or preventing infectious diseases caused by Mycobacterium tuberculosis. Specifically, the present invention relates to a compound represented by formula (I) and stereoisomer thereof, pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the compounds of the present invention, use thereof, a method for preparing the compound, in which X1, X2, R1 and R2 are described in the specification.Type: GrantFiled: March 28, 2018Date of Patent: May 17, 2022Assignee: Institute of Materia Medica, Chinese Academy of Medical SciencesInventors: Haihong Huang, Dongfeng Zhang, Hongyi Zhao
-
Publication number: 20210188871Abstract: The present invention discloses a nitrogen-containing heterocyclic substituted benzoxazine oxazolidinone compound, a preparation method and use thereof in the manufacture of a medicament for treating and/or preventing infectious diseases caused by Mycobacterium tuberculosis. Specifically, the present invention relates to a compound represented by formula (I) and stereoisomer thereof, pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the compounds of the present invention, use thereof, a method for preparing the compound, in which X1, X2, R1 and R2 are described in the specification.Type: ApplicationFiled: March 28, 2018Publication date: June 24, 2021Applicant: INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCESInventors: Haihong HUANG, Dongfeng ZHANG, Hongyi ZHAO
-
Publication number: 20200148651Abstract: The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.Type: ApplicationFiled: January 13, 2020Publication date: May 14, 2020Inventors: Christopher B. COOPER, Haihong HUANG, Dongfeng ZHANG, Nader FOTOUHI, Takushi KANEKO
-
Patent number: 10550092Abstract: The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.Type: GrantFiled: July 15, 2016Date of Patent: February 4, 2020Assignee: The Global Alliance for TB Drug Development, Inc.Inventors: Christopher B. Cooper, Haihong Huang, Dongfeng Zhang, Nader Fotouhi, Takushi Kaneko
-
Patent number: 10400203Abstract: A method for producing a living tissue and organ includes: collecting medical image information of a target tissue and organ, and converting the medical image information into three-dimensional image information; performing machine recognition and multiple feature comparisons on the three-dimensional image information, and generating a primary three-dimensional model according to physiological structure data of tissues and organs in a tissue and organ database and a residual profile of the target tissue and organ; generating a complete three-dimensional model by producing an internal microstructure of the primary three-dimensional model with reference to the tissue and organ database; producing a full-scale physical model based on the complete three-dimensional model by an additive manufacturing process; and performing a living cell-based tissue reconstruction in the full-scale physical model to produce a living tissue and organ.Type: GrantFiled: July 13, 2016Date of Patent: September 3, 2019Assignee: SHENZHEN EXCELLENT TECHNOLOGY LIMITED LIABILITY COMPANYInventors: Xiaowen Zhao, Dongfeng Zhang, Wenping Zhao, Junhua Cai
-
Publication number: 20180340149Abstract: A method for culturing osteocytes includes: obtaining an original three dimensional image of a bone tissue of a patient by collecting original image data of the bone tissue; determining a bone nidus and obtaining reverse data for fitting the bone nidus with normal bone parts other than the bone nidus by analyzing and dissecting the original three dimensional image; obtaining a preliminary three dimensional bone tissue image by simulating and matching the bone nidus and the normal bone parts other than the bone nidus based on the reverse data repeatedly; obtaining a complete three dimensional bone tissue image by designing an internal configuration of the preliminary three dimensional bone tissue image according to a bone tissue database; and obtaining a bone tissue culturing structure by printing the complete three dimensional bone tissue image through a multidimensional printer.Type: ApplicationFiled: July 19, 2016Publication date: November 29, 2018Inventors: Xiaowen ZHAO, Dongfeng ZHANG
-
Publication number: 20180298315Abstract: A method for producing a living tissue and organ includes: collecting medical image information of a target tissue and organ, and converting the medical image information into three-dimensional image information; performing machine recognition and multiple feature comparisons on the three-dimensional image information, and generating a primary three-dimensional model according to physiological structure data of tissues and organs in a tissue and organ database and a residual profile of the target tissue and organ; generating a complete three-dimensional model by producing an internal microstructure of the primary three-dimensional model with reference to the tissue and organ database; producing a full-scale physical model based on the complete three-dimensional model by an additive manufacturing process; and performing a living cell-based tissue reconstruction in the full-scale physical model to produce a living tissue and organ.Type: ApplicationFiled: July 13, 2016Publication date: October 18, 2018Inventors: Xiaowen ZHAO, Dongfeng ZHANG, Wenping ZHAO, Junhua CAI
-
Publication number: 20180179168Abstract: The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.Type: ApplicationFiled: July 15, 2016Publication date: June 28, 2018Inventors: Christopher B. COOPER, Haihong HUANG, Dongfeng ZHANG, Nader FOTOUHI, Takushi KANEKO
-
Publication number: 20170079721Abstract: A method and a system for constructing prosthesis for defect part of tissues and organs are provided. The method includes the steps of obtaining a tissue defect site of a patient; collecting original image data of the tissue defect site of the patient, restoring an original three-dimensional image of the tissue defect site and a three-dimensional image of a defect part corresponding to the defect site, and generating and storing a three-dimensional model for mending the defect part; performing simulated mending on the basis of the three-dimensional model for mending the defect part and a tissue defect model; obtaining a three-dimensional model for mending the defect part, printing the three-dimensional model for mending the defect part and generating a physical model of the prosthesis.Type: ApplicationFiled: May 4, 2016Publication date: March 23, 2017Inventors: Xiaowen Zhao, Dongfeng Zhang, Wenping Zhao, Junhua Cai
-
Patent number: 9174996Abstract: The present invention relates to compounds of Formula VIII with absolute configuration R or S: as well as pharmaceutically acceptable salts, hydrates, or solvates thereof, wherein the variables are described herein. The present invention further relates to pharmaceutical compositions which comprise the compounds of Formula VIII, and to methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.Type: GrantFiled: August 26, 2014Date of Patent: November 3, 2015Assignee: Astar Biotech LLCInventors: Chunrong Yu, Haihong Huang, Dongfeng Zhang, Peng Li
-
Patent number: 9049254Abstract: The present invention discloses a control method, an apparatus, and a system. In the embodiments of the present invention, a control command is encapsulated into a network data packet to be sent to a remote network driver interface specification (RNDIS) device, and the encapsulated network data packet is sent to the RNDIS device to control the RNDIS device. In the conventional network architecture, a user device can directly send a network data packet to an RNDIS device. Therefore, with this solution, a control command can be transmitted to the RNDIS device without adding a new control interface. Compared with the solution that requires adding a new interface and installing an additional driver program in the prior art, this solution reduces application complexity and has no special requirement for the RNDIS device, which is commonly applicable and easy to implement.Type: GrantFiled: September 21, 2011Date of Patent: June 2, 2015Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Dongfeng Zhang, Zhenhui Nie
-
Publication number: 20140364436Abstract: The present invention relates to compounds of Formula VIII with absolute configuration R or S: as well as pharmaceutically acceptable salts, hydrates, or solvates thereof, wherein the variables are described herein. The present invention further relates to pharmaceutical compositions which comprise the compounds of Formula VIII, and to methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.Type: ApplicationFiled: August 26, 2014Publication date: December 11, 2014Applicant: ASTAR BIOTECH LLCInventors: Chunrong YU, Haihong HUANG, Dongfeng ZHANG, Peng LI
-
Patent number: 8859553Abstract: The present invention relates to compounds of Formula I: as well as pharmaceutically acceptable salts, hydrates, isomers, or solvates thereof, wherein the variables are described herein. The present invention further relates to pharmaceutical compositions which comprise the compounds of Formula I, and to methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.Type: GrantFiled: July 30, 2012Date of Patent: October 14, 2014Assignee: Astar Biotech LLCInventors: Chunrong Yu, Haihong Huang, Dongfeng Zhang, Peng Li
-
Publication number: 20140243327Abstract: The present invention relates to riminophenazines having heteroaromatic substitutions, including those with 2-heteroaryl-amino substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments. A general representation of the 2-(heteroaryl)amino-riminophenazines is shown below.Type: ApplicationFiled: May 1, 2014Publication date: August 28, 2014Applicant: Global Alliance for TB Drug DevelopmentInventors: Kai Liu, Christopher B. Cooper, Haihong Huang, Chun Li, Binna Liu, Yang Liu, Zhenkun Ma, Jingbin Wang, Dali Yin, Dongfeng Zhang, Gang Zhang, Hao Zhang
-
Publication number: 20140189165Abstract: Disclosed herein is a size-minimized data logger that also serves as a housing for a secure digital (SD) memory card. The SD card housing is located on one side of the data logger. The micro-SD card is used for recording raw or digital data and digitized event data. The data logger further includes, on the opposite side from the SD card housing, different functional units which are connected to one another. Exemplary functional units include an accelerometer, a magnetometer, a time unit, a temperature sensor and at least one analog/digital converter for conversion of measurement signals into digital input data, a processor unit for processing of data, a power supply source, an input interface for receiving signals or digital data and event data, and an output interface for outputting an indicator from the data logger.Type: ApplicationFiled: December 29, 2013Publication date: July 3, 2014Applicant: Precision Life Technologies, Inc.Inventor: Dongfeng ZHANG
-
Patent number: 8716292Abstract: The present invention relates to riminophenazines having heteroaromatic substitutions, including those with 2-heteroaryl-amino substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments. A general representation of the 2-(heteroaryl)amino-riminophenazines is shown below.Type: GrantFiled: June 28, 2011Date of Patent: May 6, 2014Assignee: Global Alliance for TB Drug DevelopmentInventors: Kai Liu, Christopher B. Cooper, Haihong Huang, Chun Li, Binna Liu, Yang Liu, Zhenkun Ma, Jingbin Wang, Dali Yin, Dongfeng Zhang, Gang Zhang, Hao Zhang
-
Patent number: D984033Type: GrantFiled: December 10, 2021Date of Patent: April 18, 2023Inventor: Dongfeng Zhang